Malignant reversion of a human osteosarcoma cell line, Saos-2, by inhibition of NFκB
- 1 September 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 297 (2) , 237-241
- https://doi.org/10.1016/s0006-291x(02)02141-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- NF-κB and cell-cycle regulation: the cyclin connectionCytokine & Growth Factor Reviews, 2001
- Down-Regulation of Procollagen α1[I] Messenger RNA by Titanium Particles Correlates with Nuclear Factor κB (NF-κB) Activation and Increased Rel A and NF-κB1 Binding to the Collagen PromoterJournal of Bone and Mineral Research, 2001
- Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1Endocrine Reviews, 2000
- Inhibition of NF-κB Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related PeptideJournal of Biological Chemistry, 2000
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Cbfa1 as a regulator of osteoblast differentiation and functionBone, 1999
- Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesisNature, 1998
- Expression of the PEBP2αA/AML3/CBFA1 Gene is Regulated by BMP4/7 Heterodimer and Its Overexpression Suppresses Type I Collagen and Osteocalcin Gene Expression in Osteoblastic and Nonosteoblastic Mesenchymal CellsBone, 1998
- Osteopetrosis in mice lacking NF-κB1 and NF-κB2Nature Medicine, 1997
- Nuclear factor-κBThe International Journal of Biochemistry & Cell Biology, 1997